Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ikervis switching study in dry eye
NCT04775303Phase 4Unknown
- Sponsor
- Yonsei University
- Start
- Sep 2020
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclosporine 2% ophthalmic solution in dry eye syndrome (DED), sponsored by Yonsei University. Status: unknown.
02
Drugs
cyclosporine 2% ophthalmic solution
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT04775303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04775303.